News search

    E.g., 23/11/2024
    E.g., 23/11/2024
    Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
    Research
    1 Feb 2024
    Nature Cardiovascular Research: New approach to the design of therapies that enhance the effect of cholesterol-lowering drugs

    A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs
    Alejo Rodríguez-Fraticelli
    About the CNIC
    27 Jul 2023
    Alejo Rodríguez-Fraticelli: “The risk of cell therapies is not being able to do them fast enough in a scalable way”
    Grupo de la Dra. Priori
    Research
    21 Jul 2021
    A CNIC project receives funding from the ”la Caixa” Foundation to investigate a type of fatal tachycardia

    The research team led by project leader Dr Silvia Priori is confident that the discovery of new therapies will reduce the mortality linked to this disease and could also reduce arrhythmias in heart failure patients

    Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
    About the CNIC
    23 Dec 2020
    CNIC to coordinate a European project investigating how cancer therapies promote atherosclerosis and cardiovascular disease

    The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease
    Polypill
    Research
    23 Aug 2016
    JACC: MINERVA results demonstrate full adherence to guideline-recommended therapies associated with lower rate of a second major cardiovascular event and cost savings

    Journal of the American College of Cardiology (JACC) Publishes Data Assessing the Impact of Medication Adherence on Long-term Cardiovascular Outcomes and Cost
    Jesús Mª Vázquez Cobos, Enrique Calvo, Rebeca Acín Pérez, José Antonio Enríquez, Ana Victoria Lechuga-Vieco, Ignacio Flores, Carlos Torroja, Fátima Sánchez Cabo, Jesús Ruiz-Cabello y Andrés González Guerra.
    Research
    7 Jul 2016
    Nature: The interaction between our two genomes, nuclear and mitochondrial, is the key to healthy aging

    The study, published in Nature, provides information with important implications for mitochondrial donation therapies, which produce children with three genetic parents
    About the CNIC
    9 Nov 2015
    Group therapy is an effective and cost-efficient way to promote cardiovascular health

    Journal of the American College of Cardiology